The smart Trick of ABBV-744 preclinical studies and results That Nobody is Discussing
In Segment A, contributors will obtain distinct doses and schedules of oral ABBV-744 tablet to identify Harmless dosing routine. Further participants will probably be enrolled within the determined monotherapy dosign regimen. In Phase B, members will receive oral ruxolitinib and ABBV-744 will be specified as "insert-on" therapy. In Segment C, contr